Senseonics Wins CE Mark for One-Year CGM

Senseonics wins CE mark for one-year CGM

The company is hiring sales reps and transitioning staff from its former partner to support launches in Germany, Italy, Spain and Sweden.

Senseonics wins CE mark for Eversense 365 year-long CGM

The components of the Eversense 365 CGM. [Image courtesy of Senseonics/Ascensia]Senseonics (NYSE:SENS) announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark approval. Germantown, Maryland-based Senseonics received FDA clearance for Eversense 365 in September 2024. It launched the year-long CGM implant with its global distribution partner, Ascensia Diabetes Care, the following month. It has since taken ov…